Clinical trial
Use of DNAse in Neutrophilic Asthma
NCT03994380 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of DNAse in Neutrophilic Asthma
- Lead sponsor
- National Jewish Health
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 12, 2020
- Completion date
- December 31, 2022
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neutrophilic asthma